Registro:

Referencias:

• Ambrosi, B., Faglia, G., Faglia, G., Epidemiology of pituitary tumors i (1991) Pituitary Adenomas: New Trends in Basic and Clinical Research, pp. 159-168. , Elsevier Amsterdam New York
• Orth, D.N., Cushing's syndrome (1995) N Engl J Med., 332, pp. 791-803
• Dahia, P.L.M., Grossman, A.B., The molecular pathogenesis of corticotroph tumors (1999) Endocrine Reviews, 20 (2), pp. 136-155. , DOI 10.1210/er.20.2.136
• Wajchenberg, B.L., Albergaria Pereira, M.A., Medonca, B.B., Latronico, A.C., Carneiro, P.C., Ferreira Alves, V.A., Zerbini, M.C.N., Kirschner, M.A., Adrenocortical carcinoma: Clinical and laboratory observations (2000) Cancer, 88 (4), pp. 711-736. , DOI 10.1002/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W
• Wajchenberg, B.L., Mendonca, B.B., Liberman, B., Pereira, M.A., Carneiro, P.C., Wakamatsu, A., Ectopic adrenocorticotropic hormone syndrome (1994) Endocr Rev., 15, pp. 752-787
• Boscaro, M., Barzon, L., Fallo, F., Sonino, N., Cushing's syndrome (2001) Lancet, 357 (9258), pp. 783-791. , DOI 10.1016/S0140-6736(00)04172-6
• Miller, J.W., Crapo, L., The medical treatment of Cushing's syndrome (1993) Endocrine Reviews, 14 (4), pp. 443-458. , DOI 10.1210/er.14.4.443
• Colao, A., Di, S.A., Marzullo, P., Di, S.C., Cerbone, G., Landi, M.L., New medical approaches in pituitary adenomas (2000) Horm Res., 53 (SUPPL 3), pp. 76-87
• Melmed, S., Mechanisms for pituitary tumorigenesis: The plastic pituitary (2003) Journal of Clinical Investigation, 112 (11), pp. 1603-1618. , DOI 10.1172/JCI200320401
• Heaney, A.P., Melmed, S., Molecular targets in pituitary tumours (2004) Nature Reviews Cancer, 4 (4), pp. 285-295
• Altucci, L., Leibowitz, M.D., Ogilvie, K.M., De Lera, A.R., Gronemeyer, H., RAR and RXR modulation in cancer and metabolic disease (2007) Nature Reviews Drug Discovery, 6 (10), pp. 793-810. , DOI 10.1038/nrd2397, PII NRD2397
• Chambon, P., A decade of molecular biology of retinoic acid receptors (1996) FASEB Journal, 10 (9), pp. 940-954
• Zhang, X.K., Hoffmann, B., Tran, P.B., Graupner, G., Pfahl, M., Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors (1992) Nature., 355, pp. 441-446
• Gudas, L.J., Sporn, M.B., Roberts, A.B., (1994) The Retinoids Biology, Chemistry and Medicine, pp. 443-520. , Sporn MB, Roberts AG, and Goodman DS, editors. New York, Raven
• De Lera, A.R., Bourguet, W., Altucci, L., Gronemeyer, H., Design of selective nuclear receptor modulators: RAR and RXR as a case study (2007) Nature Reviews Drug Discovery, 6 (10), pp. 811-820. , DOI 10.1038/nrd2398, PII NRD2398
• Laudet, V., Gronemeyer, H., (2002) The Nuclear Receptor Facts Book, , Academic Press San Diego
• Pitha-Rowe, I., Petty, W.J., Kitareewan, S., Dmitrovsky, E., Retinoid target genes in acute promyelocytic leukemia (2003) Leukemia, 17 (9), pp. 1723-1730. , DOI 10.1038/sj.leu.2403065
• Lippman, S.M., Lotan, R., Advances in the development of retinoids as chemopreventive agents (2000) Journal of Nutrition, 130 (SUPPL. 2), pp. 479S-482S
• Altucci, L., Gronemeyer, H., The promise of retinoids to fight against cancer (2001) Nature Reviews Cancer, 1 (3), pp. 181-193
• Clarke, N., Germain, P., Altucci, L., Gronemeyer, H., Retinoids: Potential in cancer prevention and therapy (2004) Expert Reviews in Molecular Medicine, 6 (25). , http://www.journals.cambridge.org/action/displayFulltext?type=1&fid= 265281&jid=ERM&volumeId=6&issueId=25&aid=265279, DOI 10.1017/S1462399404008488
• Kurie, J.M., The biologic basis for the use of retinoids in cancer prevention and treatment (1999) Current Opinion in Oncology, 11 (6), pp. 497-502. , DOI 10.1097/00001622-199911000-00011
• Levin, A.A., Receptors as tools for understanding the toxicity of retinoids (1995) Toxicology Letters, 82-83, pp. 91-97. , DOI 10.1016/0378-4274(95)03546-X
• Kim, Y.W., Sharma, R.P., Li, J.K., Characterization of heterologously expressed recombinant retinoic acid receptors with natural or synthetic retinoids (1994) J Biochem Toxicol., 9, pp. 225-234
• Muindi, J.R., Frankel, S.R., Huselton, C., Degrazia, F., Garland, W.A., Young, C.W., Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia (1992) Cancer Res., 52, pp. 2138-2142
• Smith, M.A., Adamson, P.C., Balis, F.M., Feusner, J., Aronson, L., Murphy, R.F., Horowitz, M.E., Poplack, D.G., Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer (1992) Journal of Clinical Oncology, 10 (11), pp. 1666-1673
• Trump, D.L., Smith, D.C., Stiff, D., Adedoyin, A., Day, R., Bahnson, R.R., Hofacker, J., Branch, R.A., A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: A clinical trial with detailed pharmacokinetic analysis (1997) Cancer Chemotherapy and Pharmacology, 39 (4), pp. 349-356. , DOI 10.1007/s002800050582
• Conley, B.A., Egorin, M.J., Sridhara, R., Finley, R., Hemady, R., Wu, S., Tait, N.S., Van Echo, D.A., Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics (1997) Cancer Chemotherapy and Pharmacology, 39 (4), pp. 291-299. , DOI 10.1007/s002800050575
• Muindi, J., Frankel, S.R., Miller Jr, W.H., Jakubowski, A., Scheinberg, D.A., Young, C.W., Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia (1992) Blood., 79, pp. 299-303
• Kerr, I.G., Lippman, M.E., Jenkins, J., Myers, C.E., Pharmacology of 13-cis-retinoic acid in humans (1982) Cancer Res., 42, pp. 2069-2073
• Goodman, G.E., Einspahr, J.G., Alberts, D.S., Davis, T.P., Leigh, S.A., Chen, H.S., Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer (1982) Cancer Res., 42, pp. 2087-2091
• Muindi, J.R., Roth, M.D., Wise, R.A., Connett, J.E., O'Connor, G.T., Ramsdell, J.W., Schluger, N.W., Sciurba, F.C., Pharmacokinetics and metabolism of all-trans-and 13-cis-retinoic acid in pulmonary emphysema patients (2008) Journal of Clinical Pharmacology, 48 (1), pp. 96-107. , DOI 10.1177/0091270007309701
• Takitani, K., Koh, M., Inoue, A., Kawakami, C., Kuno, T., Tamai, H., Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia [2] (2006) American Journal of Hematology, 81 (9), pp. 720-721. , DOI 10.1002/ajh.20717
• Miller, V.A., Benedetti, F.M., Rigas, J.R., Verret, A.L., Pfister, D.G., Straus, D., Kris, M.G., Warrell Jr., R.P., Initial clinical trial of a selective retinoid X receptor ligand, LGD1069 (1997) Journal of Clinical Oncology, 15 (2), pp. 790-795
• Gronemeyer, H., Gustafsson, J.-A., Laudet, V., Principles for modulation of the nuclear receptor superfamily (2004) Nature Reviews Drug Discovery, 3 (11), pp. 950-964. , DOI 10.1038/nrd1551
• Zusi, F.C., Lorenzi, M.V., Vivat-Hannah, V., Selective retinoids and rexinoids in cancer therapy and chemoprevention (2002) Drug Discovery Today, 7 (23), pp. 1165-1174. , DOI 10.1016/S1359-6446(02)02526-6, PII S1359644602025266
• Dawson, M.I., Synthetic retinoids and their nuclear receptors (2004) Current Medicinal Chemistry - Anti-Cancer Agents, 4 (3), pp. 199-230. , DOI 10.2174/1568011043352975
• White, A., Gibson, S., ACTH precursors: Biological significance and clinical relevance (1998) Clinical Endocrinology, 48 (3), pp. 251-255. , DOI 10.1046/j.1365-2265.1998.00451.x
• Kovalovsky, D., Refojo, D., Liberman, A.C., Hochbaum, D., Pereda, M.P., Coso, O.A., Stalla, G.K., Arzt, E., Activation and induction of Nur77/Nurr1 in corticotrophs by CRH/cAMP: Involvement of calcium, protein kinase a, and MAPK pathways (2002) Molecular Endocrinology, 16 (7), pp. 1638-1651. , DOI 10.1210/me.16.7.1638
• Therrien, M., Drouin, J., Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements (1991) Molecular and Cellular Biology, 11 (7), pp. 3492-3503
• Boutillier, A.L., Monnier, D., Lorang, D., Lundblad, J.R., Roberts, J.L., Loeffler, J.P., Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: Characterization of an AP1 site in exon 1 (1995) Mol Endocrinol., 9, pp. 745-755
• Bousquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing (2000) J Clin Invest., 106, pp. 1417-1425
• Maira, M., Martens, C., Philips, A., Drouin, J., Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation (1999) Molecular and Cellular Biology, 19 (11), pp. 7549-7557
• Murphy, E.P., Conneely, O.M., Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors (1997) Molecular Endocrinology, 11 (1), pp. 39-47. , DOI 10.1210/me.11.1.39
• Philips, A., Lesage, S., Gingras, R., Maira, M.-H., Gauthier, Y., Hugo, P., Drouin, J., Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells (1997) Molecular and Cellular Biology, 17 (10), pp. 5946-5951
• Boutillier, A.-L., Gaiddon, C., Lorang, D., Roberts, J.L., Loeffler, J.-P., Transcriptional Activation of the Proopiomelanocortin Gene by Cyclic AMP-responsive Element Binding Protein (1998) Pituitary, 1 (1), pp. 33-43
• Paez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G.K., Retinoic acid prevents experimental Cushing syndrome (2001) Journal of Clinical Investigation, 108 (8), pp. 1123-1131. , DOI 10.1172/JCI200111098
• Wu, Q., Li, Y., Liu, R., Agadir, A., Lee, M.-O., Liu, Y., Zhang, X.-K., Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization (1997) EMBO Journal, 16 (7), pp. 1656-1669. , DOI 10.1093/emboj/16.7.1656
• Kliewer, S.A., Umesono, K., Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Evans, R.M., Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling (1992) Proc Natl Acad Sci U S A., 89, pp. 1448-1452
• Tran, P., Zhang, X.K., Salbert, G., Hermann, T., Lehmann, J.M., Pfahl, M., COUP orphan receptors are negative regulators of retinoic acid response pathways (1992) Mol Cell Biol., 12, pp. 4666-4676
• Cooney, A.J., Leng, X., Tsai, S.Y., O'Malley, B.W., Tsai, M.-J., Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors (1993) Journal of Biological Chemistry, 268 (6), pp. 4152-4160
• Fanjul, A., Dawson, M.I., Hobbs, P.D., Jong, L., Cameron, J.F., Harlev, E., Graupner, G., Pfahl, M., A new class of retinoids with selective inhibition of AP-1 inhibits proliferation (1994) Nature, 372 (6501), pp. 107-111. , DOI 10.1038/372107a0
• Morita, S., Fernandez-Mejia, C., Melmed, S., Retinoic acid selectively stimulates growth hormone secretion and messenger ribonucleic acid levels in rat pituitary cells (1989) Endocrinology, 124 (5), pp. 2052-2056
• Guibourdenche, J., Djakoure, C., Porquet, D., Pagesy, P., Rochette-Egly, C., Peillon, F., Li, J.Y., Evain-Brion, D., Retinoic acid stimulates growth hormone synthesis in human somatotropic adenoma cells: Characterization of its nuclear receptors (1997) Journal of Cellular Biochemistry, 65 (1), pp. 25-31. , DOI 10.1002/(SICI)1097-4644(199704)65:1<25::AID-JCB3>3.0.CO;2-0
• Feldman, E.C., Bruyette, D.S., Nelson, R.W., Farver, T.B., Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism (1990) Journal of the American Veterinary Medical Association, 197 (1), pp. 71-92
• Stalla, G.K., Stalla, J., Von Werder, K., Muller, O.A., Gerzer, R., Hollt, V., Jakobs, K.H., Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme (1989) Endocrinology, 125 (2), pp. 699-706
• Stalla, G.K., Stalla, J., Huber, M., Loeffler, J.P., Hollt, V., Von WK, and Muller OA: Ketoconazole inhibits corticotropic cell function in vitro (1988) Endocrinology., 122, pp. 618-623
• Labeur, M., Arzt, E., Stalla, G.K., Pez-Pereda, M., New perspectives in the treatment of cushing's syndrome (2004) Current Drug Targets: Immune, Endocrine and Metabolic Disorders, 4 (4), pp. 335-342. , DOI 10.2174/1568008043339703
• Castillo, V., Giacomini, D., Paez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Arzt, E., Retinoic acid as a novel medical therapy for Cushing's disease in dogs (2006) Endocrinology, 147 (9), pp. 4438-4444. , http://endo.endojournals.org/cgi/reprint/147/9/4438, DOI 10.1210/en.2006-0414
• Tanaka, S., Comparative Aspects of Intracellular Proteolytic Processing of Peptide Hormone Precursors: Studies of Proopiomelanocortin Processing (2003) Zoological Science, 20 (10), pp. 1183-1198. , DOI 10.2108/zsj.20.1183
• Lindblad-Toh, K., Wade, C.M., Mikkelsen, T.S., Karlsson, E.K., Jaffe, D.B., Kamal, M., Clamp, M., Lander, E.S., Genome sequence, comparative analysis and haplotype structure of the domestic dog (2005) Nature, 438 (7069), pp. 803-819. , DOI 10.1038/nature04338
• Scully, K.M., Rosenfeld, M.G., Pituitary development: Regulatory codes in mammalian organogenesis (2002) Science, 295 (5563), pp. 2231-2235. , DOI 10.1126/science.1062736
• Giacomini, D., Paez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Arzt, E., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147 (1), pp. 247-256. , http://endo.endojournals.org/cgi/reprint/147/1/247, DOI 10.1210/en.2005-0958

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------